Tilray | TRLY - Profitto Lordo Sulle Vendite





Profitto Lordo Sulle Vendite Cambiamento Data
Acasti Pharma USD 75K 30K 2021-03
Akebia Therapeutics USD 47.28M 1.7M 2025-12
Alaunos Therapeutics USD -1.13M 1.11M 2024-09
Aurora Cannabis CAD 46.62M 14.33M 2025-12
Avita Medical AUD 14.31M 639K 2025-12
Canopy Growth CAD 21.47M 434K 2025-12
Cronos Group USD 16.19M 34.52M 2025-12
Dianthus Therapeutics USD 284K 112K 2025-12
Divis Laboratories Ltd INR 16.59B 2.05B 2025-12
Ionis Pharmaceuticals USD 243M 48M 2026-03
IQVIA Holdings USD 1.07B 52M 2026-03
Knight Therapeutics CAD 64.72M 8.91M 2025-12
Moderna USD -566M 792M 2026-03
Organigram Holdings CAD 23.32M 8.52M 2025-12
Organon & Co USD 854M 3M 2025-12
Revvity USD 387.66M 34M 2026-03
Tectonic Therapeutic USD 0 0 2025-03
Tilray USD 57.47M 10.16M 2025-06
Viatris USD 1.38B 229.9M 2026-03
Xeris Pharmaceuticals USD 72.15M 8.77M 2025-12
Zealand Pharma A/S 68.91M 19.35M 2025-12